STRATA Skin Sciences, Inc. (SSKN) Cash & Current Investments (2010 - 2025)

STRATA Skin Sciences has reported Cash & Current Investments for 16 years, with the latest figure at $7.9 million in Q4 2025.

• Quarterly Cash & Current Investments fell 7.95% year-over-year to $7.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.9 million (down 7.95% YoY) and the FY2025 annual result came in at $7.9 million, down 7.95% from the prior year.
• Cash & Current Investments rose to $7.9 million in Q4 2025 per SSKN's latest filing, from $7.1 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $17.5 million in Q1 2021 and troughed at $4.2 million in Q1 2023.
• A 5-year average of $9.4 million and a median of $8.4 million in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2024: Cash & Current Investments sank 61.68% in 2023, then soared 56.98% in 2024.
• Over 5 years, Cash & Current Investments stood at $12.6 million in 2021, then tumbled by 46.01% to $6.8 million in 2022, then increased by 19.47% to $8.1 million in 2023, then grew by 5.88% to $8.6 million in 2024, then fell by 7.95% to $7.9 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $7.9 million, $7.1 million, and $6.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.